Home > Boards > US OTC > Computers - Software >

CardioComm Solutions Inc. (TSXV:EKG)

Add TSXV:EKG Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/25/2019 12:58:30 PM - Followers: 5 - Board type: Free - Posts Today: 0

CardioComm Solutions, Inc. engages in the development of software for the cardiology field worldwide. Its technology is used in products for recording, viewing, analyzing, and storing ECGs for the diagnosis and management of cardiac patients. The company's products include Global ECG Management System, a software solution for cardiac event monitoring; GlobalCardio 3 Lead; GlobalCardio 12 Lead, a Web enabled portable ECG device that is EMR compatible; ECG Viewer SDK; HeartCheck, a handheld ECG monitor; QRS 12 Lead; cardiac science atria ECG recorder; DR200/HE, a holter and event recorder; Burdick Atria 3100 ECG, an electrocardiogram system for private practices; Burdick Atria 6100 ECG, a portable ECG/EKG system for hospitals and cardiology clinics; and GEMSTrak AF, a cardiac event recorder with atrial fibrillation auto-capture. It also offers GEMS Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format, to other EMR systems that are HL7 compliant; and C4 coordinating centre for cardiac event loop monitoring services. The company sells its products to hospitals, call centers, and physician's offices through a combination of its external distribution network and sales team. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.


Editorial Contacts: CardioComm Solutions:
Christel K. Hall, APR CBC Etienne Grima, M.Sc. CHE
775-267-9232 416-977-8010 X227
christel@prowrite-pr.com egrima@cardiocommsolutions.com

CardioComm Solutions, Inc. Receives FDA Clearance to
Market First Over-the-Counter Heart Monitoring Solution
Firm Has Exclusive International Distribution of HeartCheck™ Pen &
Associated GEMS Home Software

HeartCheck™ Handheld ECG Monitors

Toronto, Canada - - January 19, 2012 - - CardioComm Solutions, Inc.
(TSX-V: EKG), a global medical provider of ECG acquisition and management
software solutions, received clearance from the Food and Drug Administration
(FDA) for over-the-counter (OTC) sales and marketing of their consumer-based,
hand-held heart rhythm monitor known as the HeartCheck™ Pen Handheld ECG.
The FDA clearance also included CardioComm Solutionsʼ GEMS™
(Global ECG Management System) Home software, which enables the
HeartCheck™ Pen to be connected to a personal computer to upload the heart
rhythm recording to CardioComm Solutionsʼ C4 medical call service telemedicine
group for review by a physician.
The HeartCheck™ Pen and GEMS™ Home solution provide an extension
to the HeartCheck™ ECG Monitor solution which may be used only under
physician direction. Both devices can communicate with CardioComm Solutionʼs
C4 medical call centre.
"Through this consumer product," said Etienne Grima, CardioComm
Solutionsʼ CEO, "we are truly putting peopleʼs heart health into their own hands."
The Pen will display only the heart rate count until an interaction with a physician
occurs. Once a C4 physician has provided review and feedback to the customer,
the Penʼs screen can be unlocked to display the real-time ECG and heart rate
count for subsequent heart rhythm recordings.
"We feel the HeartCheck™ Pen is a true remote monitoring device
because it is compact, easy to use, and takes accurate heart readings in only 30
seconds. The Pen may be used from anywhere, including at home, the office,
the gym or in remote areas which are often inaccessible to common ECG
machines," said Grima.
The HeartCheck™ Pen stores up to 20 ECGs, and its data can be
downloaded to GEMS™ Home, where repeated recordings can be managed in a
personal health data record. The GEMS™ Home software offers a simple
software user interface for managing heart rhythm recordings and associated
"What makes this product unique," explained Grima, "is that after a
consumer sends a selected heart rate recording to the C4 medical call center
over the internet using GEMS Home, the actual ECG recording will be reviewed
and interpreted by an attending C4 physician. The ECG report will then be made
available to the customer, again through GEMS™ Home, where they may
retrieve the ECG interpretation and use it in communicating with their own health
care providers."
"Any person interested in monitoring their health for primary or secondary
disease reasons would benefit from this solution," stated Michael Baber,
Business Development Director for the HeartCheck™ brand. CardioComm
Solutions is now in the process of developing market channels for the distribution
of this new device and service.
"Our cycle time for bringing this product to its current market-ready stage
has been less than 14 months, and we intend to keep the momentum going,"
reported Grima. Dr. Anatoly Langer, Chairman of the Board for CardioComm
Solutions confirms, "As a cardiologist, I believe this development represents the
cutting edge of the intersection between medicine and technology. Informed
consumers who wish to have the freedom and the security of monitoring their
health will welcome being connected when they wish to access the expertise that
comes with our leading ECG management software GEMS."
"A priority for the current year is the global commercialization of the
HeartCheck™ Pen Handheld ECG Monitor and GEMS™ Home solution," stated
Grima. "In association with the launch of this new offering, we are preparing for a
financing round with an eye toward private placement. Together with the
anticipated completion of our new GEMS™ 4.0 platform, 2012 indeed promises
to be an exciting time for CardioComm Solutions."
More Information
For more information on the HeartCheck™ Pen or any CardioComm
Solutions product or service, call the sales and marketing group at 1-877-977-
9425 toll free in the U.S. and Canada, or email sales@cardiocommsolutions.com.
About CardioComm Solutions, Inc.
CardioCommʼs patented and proprietary technology is used in products for
recording, viewing, analyzing and storing electrocardiograms (ECGs) for
diagnosis and management of cardiac patients. Products are sold worldwide
through a combination of an external distribution network and a North Americanbased
sales team. The company has earned the ISO 13485 certification, is HPB
approved, HIPAA compliant, and has received FDA market clearance for its
software devices.
CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with
offices in Victoria, B.C.


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#234   Wowsers not a post on here and yet Twisted4money 02/25/19 12:58:30 PM
#233   time to load this one ~ Blue ~ 08/07/17 09:43:41 AM
#232   wow big volume today 33% up >>> ~ Blue ~ 04/24/17 04:09:25 PM
#231   Looking into this one striker66 01/26/17 03:50:04 PM
#230   EKG.V big news out!!: CardioComm Solutions Announces ~ Blue ~ 01/06/16 12:13:38 PM
#229   $EKG http://finance.yahoo.com/news/cardiocomm-solutions-confirms-australian-regu deri21 01/26/15 01:10:35 PM
#228   not yet insiders selling shares. the biggest holder ~ Blue ~ 03/30/13 06:35:05 AM
#227   you think the bounce platform settin up on The_Edge 03/21/13 12:21:52 PM
#226   we should be seeing some numbers from the The_Edge 03/15/13 08:25:46 AM
#225   Any update from the WAISCO Distribution agreement..? http://www.wikinvest.com/st The_Edge 03/15/13 08:24:23 AM
#224   "With completion of two American distributor agreements, CardioComm The_Edge 03/06/13 01:10:06 PM
#223   EKG.V news out: CardioComm Solutions Engages National Distributor ~ Blue ~ 03/06/13 12:49:42 PM
#222   EKG.V Target Price: $14.11, Upside Potential: 10,754% ~ Blue ~ 03/05/13 10:02:27 PM
#221   EKG.V 2 million shares buyback from the open market ~ Blue ~ 03/05/13 09:01:40 PM
#220   Recently, EKG.V biggest shareholder chairman of the company ~ Blue ~ 03/05/13 08:53:20 PM
#219   EKG.V so far volume 30 times bigger than ~ Blue ~ 03/05/13 12:24:04 PM
#218   In below 20 The_Edge 03/05/13 12:21:36 PM
#217   EKG.V this time we will see 1 DOLLAR ~ Blue ~ 03/05/13 10:19:14 AM
#216   Yes Sir .. Looking good The_Edge 03/05/13 10:06:37 AM
#215   their float 35 million insiders loading big they ~ Blue ~ 03/05/13 09:58:43 AM
#214   they can sell all over the world, each ~ Blue ~ 03/05/13 09:57:46 AM
#213   Thanks for the heads up. Re-bought late Jimski 03/05/13 09:53:03 AM
#212   It looks as if additional distribution agreements are The_Edge 03/04/13 07:00:58 PM
#211   EKG.V 80% up ~ Blue ~ 03/04/13 02:40:05 PM
#210   EKG.V exploding today big news out ~ Blue ~ 03/04/13 12:57:38 PM
#209   EKG.v EXPLODING ~ Blue ~ 03/04/13 12:57:09 PM
#208   Blue.. What do you think of this one The_Edge 01/09/13 10:20:13 AM
#207   looks to be getting near load time on EKGGF The_Edge 01/09/13 10:16:04 AM
#206   Should of said "sell and go away in Stockmyser 05/03/12 07:40:56 AM
#205   This stock has been slipping of late as Stockmyser 05/03/12 07:38:36 AM
#204   http://www.marketwatch.com/story/cardiocomm-solutions-closes-private-placement-1 whats_nonprofit 03/20/12 03:16:15 PM
#203   EKG.v up 15% today so far. New high. Jimski 03/13/12 10:13:37 AM
#202   Oh yes ,a small wall at .59 and Stockmyser 03/12/12 10:39:40 PM
#201   Nice move today break 60 and it flys The_Edge 03/12/12 03:42:05 PM
#200   EKG, i guess this time 1 dollar target ~ Blue ~ 03/08/12 02:26:00 PM
#199   Someone on a different site posted this, very whats_nonprofit 03/08/12 02:13:51 PM
#198   BIG NEWS Japanese ARE INTERESTED IN EKG ~ Blue ~ 03/08/12 02:06:51 PM
#197   I've heard anywhere from $78.00 to $99.00 plus Stockmyser 03/08/12 01:00:30 PM
#196   Yeah, I've been reading all those posts. Do whats_nonprofit 03/08/12 12:40:02 PM
#195   Million preorder rumour. Rumours on stockhouse of over Jimski 03/08/12 12:38:24 PM
#194   It's a longer halt than normal. whats_nonprofit 03/08/12 12:32:11 PM
#193   EKG.v halted Jimski 03/08/12 10:33:32 AM
#192   Keep a close eye on EKG next week Stockmyser 02/17/12 05:48:43 PM
#191   This stock is poised to make a big Stockmyser 02/15/12 10:40:11 PM
#190   EKG.V Target Price: $14.11, Upside Potential: 2,419% ~ Blue ~ 02/13/12 08:47:19 AM
#189   They are gonna sell 1 device 765 dollars. HUGE ~ Blue ~ 02/11/12 01:44:55 PM
#188   Long term target looking reachable. Holding some for The_Edge 02/10/12 09:18:11 PM
#187   Wallstreet Reporter: CEO interview http://www.cardiocommsolutions.com/news/wallstreetreporte ~ Blue ~ 02/10/12 07:53:59 PM
#186   EKG.V 45.45 % up volume 13.7 million GREAATTTTT ~ Blue ~ 02/10/12 04:14:11 PM
#185   me too, only a fool would sell just tgler 02/10/12 03:30:07 PM